Pulsatile systems for colon targeting of budesonide: In vitro and in vivo evaluation

Drug Delivery

Volumn 18, Issue 8, 2011, Pages 620-630

  Yehia, Soad A ^a   Elshafeey, Ahmed H ^a   Elsayed, Ibrahim ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Budesonide; Colon targeting; Eudragit S100; Guar gum; Myeloperoxidase activity; Pulsatile; Spray coating

Indexed keywords

BUDESONIDE; CELLABURATE; EUDRAGIT RS; GUAR GUM; HYDROXYPROPYLMETHYLCELLULOSE; MYELOPEROXIDASE; PECTIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCENDING COLON; COLITIS; COLON; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG CAPSULE; DRUG COATING; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; FEMALE; GASTROINTESTINAL RADIOGRAPHY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PULSATILE DRUG RELEASE; RABBIT; TARGET ORGAN; TIMED DRUG RELEASE; TRANSVERSE COLON;

ADMINISTRATION, ORAL; ADULT; ANIMALS; BIOLOGICAL AVAILABILITY; BUDESONIDE; CAPSULES; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; COLITIS; COLON; COLON, TRANSVERSE; DELAYED-ACTION PREPARATIONS; GALACTANS; HUMANS; HYDROGEN-ION CONCENTRATION; ILEUM; LACTOSE; MALE; MANNANS; MANNOSIDASES; METHYLCELLULOSE; PECTINS; PEROXIDASE; PLANT GUMS; POLYGALACTURONASE; POLYMETHACRYLIC ACIDS; RABBITS; RECTUM; STOMACH; TABLETS; TRINITROBENZENESULFONIC ACID; YOUNG ADULT;

EID: 82055161857     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2011.621987     Document Type: Article

References (32)

1. Baker, D.E. (2001). Budesonide modified release capsules. Rev Gastroenterol Disord. 1:147-55
2. Cui, N., Friend, D.R., Fedorak, R.N. (1994). A budesonide prodrug accelerates treatment of colitis in rats. Gut. 3510:1439-46. (Pubitemid 24310908)
3. Depoortere, I., Van Assche, G., Thijs, T., Geboes, K., Peeters, T.L. (1999). Differential changes in ACh-, motilin-, substance P-, and K(+)-induced contractility in rabbit colitis. Am J Physiol. 277:61-8.
4. Edsbäcker, S., Bengtsson, B., Larsson, P., Lundin, P., Nilsson, A., Ulmius, J., Wollmer, P. (2003). A pharmacoscintigraphic evaluation of oral budesonide given as controlled-release (Entocort) capsules. Aliment Pharmacol Ther. 15:525-36. (Pubitemid 36388753)
5. Feagan, B.G., Sandborn, W.J. (2002). Initial therapy for mild to moderate Crohns disease: Mesalmaine or budesonide? Rev Gastroenterol Disord. 2:s9-s15. (Pubitemid 35422993)
6. Gliko-Kabir, I., Yagen, B., Baluom, M., Rubinstein, A. (2000). Phosphated crosslinked guar for colon-specific drug delivery. II. In vitro and in vivo evaluation in the rat. J Contr Rel. 63:129-34. (Pubitemid 30046948)
7. Hinton, J.M., Lennard-Jonnes, J.E., Young, A.C. (1969). A new method for studying gut transit times using radioopaque markers. Gut. 10:842.
8. Ibekwe, V.C., Fadda, H.M., Parsons, G.E., Basit, A.W. (2006a). A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery. Int J Pharm. 308:52-60. (Pubitemid 43097235)
9. Ibekwe, V.C., Liu, F., Fadda, H., Khela, M.K., Evans, D.F., Parsons, G.E., Basit, A.W. (2006b). An Investigation into the in vivo performance variability of pH responsive polymers for ileo-colonic drug delivery using gamma scintigraphy in humans. J Pharm Sci. 95:2760-6. (Pubitemid 46093182)
10. Jeong, Y.I., Ohno, T., Hu, Z., Yoshikawa, Y., Shibata, N., Nagata, S., Takada, K. (2001). Evaluation of an intestinal pressure-controlled colon delivery capsules prepared by a dipping method. J Contr Rel. 71:175-82. (Pubitemid 32234378)
11. Kakoulides, E.P., Smart, J.D., Tsibouklis, J. (1998). Azocrosslinked poly (acrylic acid) for colonic delivery and adhesion specificity: Synthesis and characterization. J Contr Rel. 52:291-300.
12. Kaus, L.C., Fell, J.T., Sharma, H., Taylor, D.C. (1984). The intestinal transit of a single non-disintegrating object. Int J Pharm. 14:143-8.
13. Klotz, U., Schwab, M. (2005). Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease. Adv Drug Deliv Rev. 57:267-79. (Pubitemid 39536102)
14. Krishnaiah, Y.S., Satyanarayana, V., Dinesh Kumar, B., Karthikeyan, R.S. (2002). In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil. Eur J Pharm Sci. 16:185-92. (Pubitemid 34786453)
15. Krishnamachari, Y., Madan, P., Lin, S. (2007). Development of pHand time-dependent oral microparticles to optimize budesonide delivery to ileum and colon. Int J Pharm. 338:238-47. (Pubitemid 46777247)
16. Mastiholimath, V.S., Dandagi, P.M., Jain, S.S., Gadad, A.P., Kulkarni, A.R. (2007). Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma. Int J Pharm. 328:49-56. (Pubitemid 44827555)
17. McConville, J.T., Ross, A.C., Chambers, A.R., Smith, G., Florence, A.J., Stevens, H.N.E. (2004). The effect of wet granulation on the erosion behaviour of an HPMC-lactose tablet, used as a rate-controlling component in a pulsatile drug delivery capsule formulation. Eur J Pharm Biopharm. 57:541-9. (Pubitemid 38490573)
18. Ritger, P.L., Peppas, N.A. (1987). A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Contr Rel. 5:37-42. (Pubitemid 17106644)
19. Rodriguez, M., Antunez, J.A., Taboada, C., Seijo, B., Torres, D. (2001). Colon-specific delivery of budesonide from microencapsulated cellulosic cores: evaluation of the efficacy against colonic inflammation in rats. J Pharm Pharmacol. 53:1207-1215. (Pubitemid 32904015)
20. Rodriguez, M., Vila-Jato, J.L., Torres, D. (1998). Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J Contr Rel. 55:67-77. (Pubitemid 28477565)
21. Rönnblom, A., Samuelsson, S.M., Ekbom, A. (2010). Ulcerative colitis in the county of Uppsala 1945-2007: Incidence and clinical characteristics. J Crohns Colitis. 4:532-6.
22. Sawada, T., Sako, K., Fukui, M., Yokohamaa, S., Hayashi, M. (2003). A new index, the core erosion ratio, of compression-coated timedrelease tablets predicts the bioavailability of acetaminophen. Int J Pharm. 265:55-63. (Pubitemid 37176946)
23. Schellekens, R.C.A., Stellaard, F., Olsder, G.G., Woerdenbag, H.J., Frijlink, H.W., Kosterink, J.G.W. (2010). Oral ileocolonic drug delivery by the colopulse-system: A bioavailability study in healthy volunteers. J Contr Rel. 146:334-40.
24. Shin, D.H., Sinn, D.H., Kim, Y.H., Kim, J.Y., Chang, D.K., Kim, E.J., Ryu, H.Y., Song, H.U., Kim, I.Y., Kim do, H., Kim, Y.Y., Kim, S.H., Seo, Y.B., Hwang, K.W., Kim, J.J. (2011). Increasing incidence of inflammatory bowel disease among young men in Korea between 2003 and 2008. Dig Dis Sci. 56:1154-9.
25. Tozaki, H., Komoike, J., Tada, C., Maruyama, T., Terabe, A., Suzuki, T., Yamamoto, A., Muranishi, S. (1997). Chitosan capsules for colonspecific drug delivery: Improvement of insulin absorption from the rat colon. J Pharm Sci. 86:1016-21. (Pubitemid 27382903)
26. Turkoglu, M., Ugurlu, T. (2002). In vitro evaluation of pectin-HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery. Eur J Pharm Biopharm. 53:65-73. (Pubitemid 34036999)
27. Wilding, I.R., Davis, S.S., Bakhshaee, M., Stevens, H.N., Sparrow, R.A., Brennan, J. (1992). Gastrointestinal transit and systemic absorption of captopril from a pulsed-release formulation. Pharm Res. 9:654-7.
28. Wilson, J., Hair, C., Knight, R., Catto-Smith, A., Bell, S., Kamm, M., Desmond, P., McNeil, J., Connell, W. (2010). High incidence of inflammatory bowel disease in Australia: A prospective population-based Australian incidence study. Inflamm Bowel Dis. 16:1550-6.
29. Wong, D., Larrabee, S., Clifford, K., Tremblay, J., Friend, D. (1997). USP dissolution apparatus III (reciprocating cylinder) for screening of guar-based colonic delivery formulations. J Contr Rel. 47:173-9. (Pubitemid 27212344)
30. Yehia, S.A., Elshafeey, A.H., Sayed, I., Shehata, A.H. (2009). Optimization of budesonoide compression-coated tablets for colonic delivery. AAPS PharmSciTec. 10:147-57.
31. Yu, D.K., Morrill, B., Eichmeier, L.S. (1995). Pharmacokinetics of 5-aminosalicylic acid in man. Eur J Clin Pharmacol. 48:273-7.
32. Zheng, J.J., Zhu, X.S., Huangfu, Z., Shi, X.H., Guo, Z.R. (2010). Prevalence and incidence rates of Crohns disease in mainland China: A meta-analysis of 55 years of research. J Dig Dis. 11:161-6.